The landscape of dementia analysis has evolved considerably with the advent of refined biomarkers, together with amyloid PET scans, tau imaging, and blood-based tests that will detect Alzheimer's pathology several years right before symptoms emerge. Whilst these technological developments represent exceptional progress in comprehension neurodegener